Doctor profile · Federal record

Dr. Christopher Ha, M.D.

Dermatology Physician (CMS: Dermatology) · Roseville, CA

  • NPI 1194764738
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 32 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1412 Blue Oaks Blvd
Roseville, CA 957477143
(916) 784-7546
fax (916) 784-7548

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
January 10, 2013
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
California #A60428

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1194764738. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
7,570
Distinct HCPCS
10
Medicare allowed
$490,999
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 2,710 447 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 1,333 890 $95
17000 Destruction of precancer skin growth, 1 growth 794 555 $51
11102 Biopsy of related skin growth, first growth 674 495 $98
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application 408 19 $131
17110 Destruction of skin growth, 1-14 growths 386 312 $122
11103 Biopsy of related skin growth, each additional growth 298 173 $55
99214 Established patient office or other outpatient visit, 30-39 minutes 282 208 $133
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 125 28 $1
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 78 72 $186

In context: peer comparison

Among 8 peers in this city , average services per provider: 410. This provider delivers 18× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,028
Transactions
141
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 50 $1,850.22
GENZYME CORPORATION 11 $343.35
REVANCE THERAPEUTICS, INC. 5 $327.06
LEO Pharma Inc. 15 $230.03
E.R. Squibb & Sons, L.L.C. 13 $213.94
Lilly USA, LLC 14 $205.31
Novartis Pharmaceuticals Corporation 8 $196.39
Regeneron Healthcare Solutions, Inc. 4 $192.84
Incyte Corporation 5 $99.86
SUN PHARMACEUTICAL INDUSTRIES INC. 5 $79.26
Amgen Inc. 3 $52.79
Janssen Biotech, Inc. 2 $45.81
Dermavant Sciences, Inc. 2 $42.28
Ortho Dermatologics, a division of Bausch Health US, LLC 2 $38.04
PFIZER INC. 2 $37.04

By nature of payment

Food and Beverage
$2,831
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$1,188
Education
$8

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
316
Patients
139
Total drug cost
$209,745
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 65 49 $669
Ketoconazole Generic 37 0 $1,014
Clobetasol Propionate Generic 36 26 $2,311
Fluorouracil Generic 29 26 $1,988
Doxycycline Monohydrate Generic 25 13 $483
Valacyclovir (Valacyclovir Hcl) Brand 23 13 $590
Taltz Autoinjector (Ixekizumab) Brand 20 0 $145,636
Cephalexin Generic 15 12 $119
Dupixent Pen (Dupilumab) Brand 15 0 $53,693
Clindamycin Phosphate Generic 14 0 $437

Frequently asked questions

Auto-generated from federal data
What is Dr. Christopher Ha's medical specialty?
Dr. Christopher Ha practices Dermatology Physician in Roseville, CA.
Where does Dr. Christopher Ha practice?
Dr. Christopher Ha practices at 1412 Blue Oaks Blvd, Roseville, CA 957477143. Office phone: 9167847546.
What is Dr. Christopher Ha's NPI?
Dr. Christopher Ha's National Provider Identifier (NPI) is 1194764738, issued by NPPES.
Does Dr. Christopher Ha accept Medicare assignment?
Yes. Dr. Christopher Ha accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Ha commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.